AstraZeneca and Daiichi Sankyo’s star drug Enhertu has delivered a double knockout, showing its ability to stave off early ...
Merck’s efforts to make headway in a cancer type that was an elusive target for its superstar oncology med Keytruda proves to ...
The combination of Merck’s Keytruda and Pfizer and Astellas’ Padcev reduced patients' risk of death by a whopping 50% when used before and after bladder removal surgery in those with MIBC who are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback